Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Stallard

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Statistics in Medicine|March 2, 2010
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint informationNigel Stallard
Statistics in Medicine|November 5, 2011
Optimal sample sizes for phase II clinical trials and pilot studiesNigel Stallard
Statistical Methods in Medical Research|September 25, 2024
Testing for a treatment effect in a selected subgroupNigel Stallard
Biometrical Journal. Biometrische Zeitschrift|March 3, 2018
Editorial for the Biometrical Journal Special Issue ISCB 2016Nigel Stallard
Statistics in Medicine|August 6, 2008
Simple tests for the external validation of mortality prediction scoresNigel Stallard
Biometrics|August 21, 2003
Decision-theoretic designs for phase II clinical trials allowing for competing studiesNigel Stallard
Journal of Biopharmaceutical Statistics|April 26, 2011
Group-sequential methods for adaptive seamless phase II/III clinical trialsNigel Stallard
Biometrics|February 17, 2022
Adaptive enrichment designs with a continuous biomarkerNigel Stallard
Biometrics|April 1, 2022
Rejoinder to discussion on "Adaptive enrichment designs with a continuous biomarker"Nigel Stallard
Alternatives to Laboratory Animals : ATLA|December 17, 2004
Opportunities for reduction in acute toxicity testing via improved designAnne Whitehead, Nigel Stallard
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Statistics in Medicine|March 2, 2010
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint informationNigel Stallard
Statistics in Medicine|November 5, 2011
Optimal sample sizes for phase II clinical trials and pilot studiesNigel Stallard
Statistical Methods in Medical Research|September 25, 2024
Testing for a treatment effect in a selected subgroupNigel Stallard
Biometrical Journal. Biometrische Zeitschrift|March 3, 2018
Editorial for the Biometrical Journal Special Issue ISCB 2016Nigel Stallard
Statistics in Medicine|August 6, 2008
Simple tests for the external validation of mortality prediction scoresNigel Stallard
Biometrics|August 21, 2003
Decision-theoretic designs for phase II clinical trials allowing for competing studiesNigel Stallard
Journal of Biopharmaceutical Statistics|April 26, 2011
Group-sequential methods for adaptive seamless phase II/III clinical trialsNigel Stallard
Biometrics|February 17, 2022
Adaptive enrichment designs with a continuous biomarkerNigel Stallard
Biometrics|April 1, 2022
Rejoinder to discussion on "Adaptive enrichment designs with a continuous biomarker"Nigel Stallard
Alternatives to Laboratory Animals : ATLA|December 17, 2004
Opportunities for reduction in acute toxicity testing via improved designAnne Whitehead, Nigel Stallard
Pageof 16